Innocan Pharma Corp. buy Indyro
Start price
15.09.21
/
80%
€0.70
Target price
15.09.22
€2.00
Performance (%)
-41.34%
End price
17.05.22
€0.41
Summary
This prediction ended on 17.05.22 with a price of €0.41. Massive losses of -41.34% were the result for the BUY prediction by Indyro. Indyro has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innocan Pharma Corp. | - | - | - | - |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% | 68.627% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% | 116.238% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% | 56.217% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% | 70.924% |
Comments by Indyro for this prediction
In the thread Innocan Pharma Corp. diskutieren
Buy Innocan Pharma Corp.